Ozturk, N. Et Al. 2021. Rosuvastatin Reduces L-Type Ca2+ Current and Alters Contractile Function in Cardiac Myocytes via Modulation of beta-Adrenergic Receptor Signaling. CARDIOVASCULAR TOXICOLOGY , vol.21, no.5 , 422-431.

Ozturk, N., USLU, S., Mercan, T., ERKAN, O., & ÖZDEMİR, S., (2021). Rosuvastatin Reduces L-Type Ca2+ Current and Alters Contractile Function in Cardiac Myocytes via Modulation of beta-Adrenergic Receptor Signaling. CARDIOVASCULAR TOXICOLOGY , vol.21, no.5, 422-431.

Ozturk, NİHAL Et Al. "Rosuvastatin Reduces L-Type Ca2+ Current and Alters Contractile Function in Cardiac Myocytes via Modulation of beta-Adrenergic Receptor Signaling," CARDIOVASCULAR TOXICOLOGY , vol.21, no.5, 422-431, 2021

Ozturk, NİHAL Ö. Et Al. "Rosuvastatin Reduces L-Type Ca2+ Current and Alters Contractile Function in Cardiac Myocytes via Modulation of beta-Adrenergic Receptor Signaling." CARDIOVASCULAR TOXICOLOGY , vol.21, no.5, pp.422-431, 2021

Ozturk, N. Et Al. (2021) . "Rosuvastatin Reduces L-Type Ca2+ Current and Alters Contractile Function in Cardiac Myocytes via Modulation of beta-Adrenergic Receptor Signaling." CARDIOVASCULAR TOXICOLOGY , vol.21, no.5, pp.422-431.

@article{article, author={NİHAL ÖZTÜRK ERBOĞA Et Al. }, title={Rosuvastatin Reduces L-Type Ca2+ Current and Alters Contractile Function in Cardiac Myocytes via Modulation of beta-Adrenergic Receptor Signaling}, journal={CARDIOVASCULAR TOXICOLOGY}, year=2021, pages={422-431} }